Psoriasis in older adults: risk factors at Centro Gerontológico

Authors

Keywords:

PSORIASIS, PATHOLOGY, GERONTOLOGIC, OLDER ADULTS.

Abstract

Introduction: one of the most common skin conditions is psoriasis, a disease that has received great attention from physicians and researchers, becoming a model to study chronic inflammation.

Objective: to identify risk factors present in older adults with psoriasis.

Methods: observational, descriptive, cross-sectional, cross-sectional study, conducted in a sample of 16 older adults belonging to the "Mi Abuelito" Comprehensive Care Center for the Elderly in Riobamba, Ecuador, during the period 2021-2022. The documentary review and physical examination of the patient allowed obtaining information that led to the variables studied. Medical ethics were respected.

Results: female sex predominated (62,5 %), with the 75 to 89 years age group being the most representative (56,3 %). Thirty percent of the patients presented incidence regarding the use of drugs, mainly antihypertensive, anti-inflammatory and antidepressant drugs. Metabolic syndromes predominated in 20 %, with 17 % showing a family history of psoriasis and overweight.

Conclusions: among the risk factors for psoriasis, the genetic factor is the most relevant, specifying that the use of some drugs, the presence of metabolic syndromes and overweight were the main triggering factors identified in the study. In view of this, it is necessary to apply a comprehensive and multidisciplinary care approach in patients with psoriasis, especially if there are other related diseases that are not identified and that can negatively influence the recovery and outcome of the disease.

 

Downloads

Download data is not yet available.

References

1. Giniebra Marín GM, Gorrín Díaz Y, Rivera Rivadulla R, Linares Cánovas LP. Most frequent dermatoses in the elderly of Pinar del Río. Rev Ciencias Médicas [Internet]. 2020 Feb [citado 23/06/24]; 24(1): 115-122. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-31942020000100115&lng=es

2. Arenas Guzmán R. Dermatología. La piel. En: Colectivo de autores. Dermatología. Atlas, diagnóstico y tratamiento [Internet]. 6ta Edición. McGraw Hill Medical [citado 23/06/24]. Disponible en: https://accessmedicina.mhmedical.com/content.aspx?bookid=1538&sectionid=102302563

3. Inga TAS, Quiroga FDP, Morillo JCM, Cuamacás EDG. Actualización en el manejo de la psoriasis. RECIMUNDO [Internet]. 2023 [citado 23/06/24]; 7(1): 197-206. Disponible en: https://www.recimundo.com/index.php/es/article/view/1943

4. Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. The Lancet [Internet]. 2007 [citado 23/06/24]; 370(9583): 263-71. Disponible en: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(07)61128-3/abstract

5. Boehncke WH, Brembilla NC. Pathogenesis-oriented therapy of psoriasis using biologics. Expert Opin Biol Ther [Internet]. 2022 Dec [citado 23/06/24]; 22(12): 1463-1473. Disponible en: https://doi.org/10.1080/14712598.2022.2100219

6. Hawkes JE, Chan TC, Krueger JG. Psoriasis pathogenesis and the development of novel targeted immune therapies. J Allergy Clin Immunol [Internet]. 2017 [citado 23/06/24]; 140(3): 645-53. Disponible en: https://www.sciencedirect.com/science/article/pii/S0091674917311971

7. López N, Baltazar A, González LF. Factores de riesgo y comorbilidades en pacientes con psoriasis. MEDISAN [Internet]. 2019 [citado 23/06/24]; 23(3): 435-46. Disponible en: http://scielo.sld.cu/scielo.php?pid=S1029-30192019000300435&script=sci_arttext&tlng=pt

8. Ogawa K, Okada Y. The current landscape of psoriasis genetics in 2020. J Dermatol Sci [Internet]. 2020 [citado 23/06/24]; 99(1): 2-8. Disponible en: https://www.sciencedirect.com/science/article/pii/S0923181120301766

9. Otero RAT, Cuesta clara DP, Llangary GMV, Reyes BEM. Factores de Riesgo y desencadenantes de la Psoriasis: estudio de revisión. J Am Health [Internet]. 2021 [citado 23/06/24]. Disponible en: https://jah-journal.com/index.php/jah/article/view/87

10. O'Sullivan D, Chung C, Lee K, Kim E, Kang S, Kim T, et al. Measurement and comparison of taekwondo and yongmudo turning kick impact force for two target heights. J Sports Sci Med [Internet]. 2019 [citado 23/06/24]; 8(CSSI3). Disponible en: https://pubmed.ncbi.nlm.nih.gov/24474880/

11. Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M. Risk Factors for the Development of Psoriasis. Int J Mol Sci [Internet]. 2019 [citado 23/06/24]; 20(18): 4347. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31491865/

12. Jensen P, Skov L. Psoriasis and Obesity. Dermatol Basel Switz [Internet]. 2016 [citado 23/06/24]; 232(6): 633-9. Disponible en: https://pubmed.ncbi.nlm.nih.gov/28226326/

13. Brembilla NC, Boehncke WH. Dermal adipocytes’ claim for fame in psoriasis. Exp Dermatol [Internet]. 2017 [citado 23/06/24]; 26(5): 392-3. Disponible en: https://pubmed.ncbi.nlm.nih.gov/27193510/

14. Cao H. Adipocytokines in Obesity and Metabolic Disease. J Endocrinol [Internet]. 2020 [citado 23/06/24]; 220(2): T47. Disponible en: https://pubmed.ncbi.nlm.nih.gov/24403378/

15. Bonanad C, González-Parra E, Rivera R, Carrascosa JM, Daudén E, Olveira A, et al. Implicaciones clínicas, diagnósticas y terapéuticas de la psoriasis y enfermedad cardiovascular. Actas Dermo-Sifiliográficas [Internet]. 2017 [citado 23/06/24]; 108(9): 800-8. Disponible en: https://www.sciencedirect.com/science/article/pii/S0001731017301953

Downloads

Published

2024-08-04

How to Cite

1.
Guevara-Guaman VK, Cuello-Freire GE, Vallejo-Ordoñez GM. Psoriasis in older adults: risk factors at Centro Gerontológico. Univ. Méd. Pinareña [Internet]. 2024 Aug. 4 [cited 2025 Apr. 19];20:e1154. Available from: https://revgaleno.sld.cu/index.php/ump/article/view/1154

Issue

Vol. 20 (2024): (Sistema de Publicación Continua)

Section

Original Article

License

Authors who have published with this journal accept the following terms: authors will retain their copyright and guarantee the journal the right of first publication of their work, which will be simultaneously subject to the Creative Commons recognition license that allows third parties to share the work as long as its author is indicated and its first publication is this journal. Authors may adopt other non-exclusive license agreements for the distribution of the version of the published article (e.g., deposit it in an institutional telematic archive or publish it in a monographic volume) provided that the initial publication in this journal is indicated. Authors are permitted and encouraged to disseminate their article using Internet (e.g., in institutional telematic archives or on their website) before and during the submission process, which may lead to interesting exchanges and increased citations of the published work. (See The Effect of Open Access).